Meeting to be held on April 29 hosted by Oppenheimer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNSE:
- Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
- Sensei Biotherapeutics management to meet with Oppenheimer
- Sensei Biotherapeutics Extends Relationship with Former CFO
- Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference
- Sensei Biotherapeutics: Peer-reviewed research paper on SNS-101 published
Questions or Comments about the article? Write to editor@tipranks.com